Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Wojcierowska-Litwin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Clinical Medicine|November 27, 2021
The Relationship of <i>ABCB1/MDR1</i> and <i>CYP1A1</i> Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple MyelomaSzymon Zmorzynski, Magdalena Wojcierowska-Litwin, Sylwia Popek-Marciniec, et al.
Biomed Research International|March 19, 2020
<i>NOTCH3</i> T6746C and <i>TP53</i> P72R Polymorphisms Are Associated with the Susceptibility to Diffuse Cutaneous Systemic SclerosisSzymon Zmorzyński, Magdalena Wojcierowska-Litwin, Małgorzata Kowal, et al.
Journal of Strength and Conditioning Research|February 6, 2018
ACTN3 Genotype in Professional Sport ClimbersMichał Ginszt, Małgorzata Michalak-Wojnowska, Piotr Gawda, et al.
Journal of Clinical Medicine|March 29, 2023
The Relationship of <i>CCL5</i> and <i>CCR1</i> Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple MyelomaSylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, et al.
Frontiers in Oncology|November 5, 2019
The Association of <i>GSTT1, GSTM1</i>, and <i>TNF-</i>α Polymorphisms With the Risk and Outcome in Multiple MyelomaSzymon Zmorzyński, Sylwia Popek-Marciniec, Aneta Szudy-Szczyrek, et al.
Cancers|October 14, 2023
Association of Chromosome 17 Aneuploidy, <i>TP53</i> Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib TreatmentSylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, et al.
Life (Basel, Switzerland)|September 28, 2021
The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis DevelopmentJoanna Bartosińska, Szymon Zmorzyński, Beata Sarecka-Hujar, et al.
Frontiers in Oncology|February 22, 2019
<i>ACE</i> Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple MyelomaSzymon Zmorzynski, Aneta Szudy-Szczyrek, Sylwia Popek-Marciniec, et al.
Folia Histochemica Et Cytobiologica|January 16, 2018
TP53 polymorphism in plasma cell myelomaSzymon Andrzej Zmorzynski, Iwona Korszen-Pilecka, Magdalena Wojcierowska-Litwin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Clinical Medicine|November 27, 2021
The Relationship of <i>ABCB1/MDR1</i> and <i>CYP1A1</i> Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple MyelomaSzymon Zmorzynski, Magdalena Wojcierowska-Litwin, Sylwia Popek-Marciniec, et al.
Biomed Research International|March 19, 2020
<i>NOTCH3</i> T6746C and <i>TP53</i> P72R Polymorphisms Are Associated with the Susceptibility to Diffuse Cutaneous Systemic SclerosisSzymon Zmorzyński, Magdalena Wojcierowska-Litwin, Małgorzata Kowal, et al.
Journal of Strength and Conditioning Research|February 6, 2018
ACTN3 Genotype in Professional Sport ClimbersMichał Ginszt, Małgorzata Michalak-Wojnowska, Piotr Gawda, et al.
Journal of Clinical Medicine|March 29, 2023
The Relationship of <i>CCL5</i> and <i>CCR1</i> Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple MyelomaSylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, et al.
Frontiers in Oncology|November 5, 2019
The Association of <i>GSTT1, GSTM1</i>, and <i>TNF-</i>α Polymorphisms With the Risk and Outcome in Multiple MyelomaSzymon Zmorzyński, Sylwia Popek-Marciniec, Aneta Szudy-Szczyrek, et al.
Cancers|October 14, 2023
Association of Chromosome 17 Aneuploidy, <i>TP53</i> Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib TreatmentSylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, et al.
Life (Basel, Switzerland)|September 28, 2021
The Genetic Variants of NOTCH3 (6746T>C) and PSMA6 (-8C>G) as Possible Risk Factors of Psoriasis DevelopmentJoanna Bartosińska, Szymon Zmorzyński, Beata Sarecka-Hujar, et al.
Frontiers in Oncology|February 22, 2019
<i>ACE</i> Insertion/Deletion Polymorphism (rs4646994) Is Associated With the Increased Risk of Multiple MyelomaSzymon Zmorzynski, Aneta Szudy-Szczyrek, Sylwia Popek-Marciniec, et al.
Folia Histochemica Et Cytobiologica|January 16, 2018
TP53 polymorphism in plasma cell myelomaSzymon Andrzej Zmorzynski, Iwona Korszen-Pilecka, Magdalena Wojcierowska-Litwin, et al.
Pageof 1